Sign in
4

Changes in Ownership

LENZ Therapeutics, Inc. Filed Acc 0001209191-21-066742

10% owner bought 201,685 shares at $10.15 ($2,047,103)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Samsara BioCapital, L.P. 10% owner 2021-11-22 Purchase +201,685 $10.15 $2,047,103 7,791,851 I: show line 1 in the form
Open-market purchases · 201,685 sh · avg $10.15 · $2,047,103
Loading xslF345X03/doc4.xml…